Perioperative medicine & outcomes

Reliability and validity of a new postoperative track assessment tool (PoTra-tool) as a decision-making aid: A prospective observational study

Eur J Anaesthesiol Intensive CarePublished Prospective observational study

Authors' conclusion

The PoTra-tool may support the decision-making process in deciding the most appropriate peri-operative level of care for an individual patient: PACU with standard care or IMCU with specialised care.

Study context

Population
Postoperative patients in a postanaesthesia care unit (PACU) and a specialised peri-operative intermediate care unit (IMCU) of a Swiss university hospital; raters were nurses and physicians of different competency levels4,206 ratings
Participants
879 patients
Exposure
PoTra-tool ratings in PACU vs IMCU patients
Outcome
Reliability (between raters and across days; Intraclass correlation coefficients (ICCs) or weighted kappas) and validity (vs severity of illness, nurse workload and predicted mortality scores) of the PoTra-tool (VASi and VASb)
Methodological detailsTool tested on day 0 in both units and on day 1 in the IMCU
  • Tool tested on day 0 in both units and on day 1 in the IMCU

Main finding

As reported in the abstract

Reliability and validity of VASi and VASb

Internal consistency between VASi and VASb (Pearson correlation)

0.90

Inter-rater reliability of VASi and VASb, each type of rater (weighted kappas), acceptable to moderate

0.59 to 0.67

Observational data: associations, not effects.

Further findings

Median

OutcomePACUIMCU
VASi (estimated indication for IMCU care)12 (IQR 2–30)76 (IQR 57–89)
VASb (estimated benefit of IMCU care)7 (IQR 1–19)66 (IQR 43–84)

Original publication

Reliability and validity of a new postoperative track assessment tool (PoTra-tool) as a decision-making aid: A prospective observational study. Eur J Anaesthesiol Intensive Care. Published 29 May 2025. doi:10.1097/ea9.0000000000000076

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.